Positions

Selected Publications

Academic Article

Year Title Altmetric
2021 The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancerArchives of Pathology and Laboratory Medicine.  145:461-493. 2021
2021 Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer[Formula presented]European Urology.  79:364-371. 2021
2021 Identification of BXDC2 as a key downstream effector of the androgen receptor in modulating cisplatin sensitivity in bladder cancerCancers.  13:1-13. 2021
2021 Molecular biomarker testing in localized prostate cancer the critical role of pathologistsArchives of Pathology and Laboratory Medicine.  145:264-265. 2021
2020 Expression of nectin-4 and pd-l1 in upper tract urothelial carcinomaInternational Journal of Molecular Sciences.  21:1-13. 2020
2020 The role of adipocytokines and their receptors in bladder cancer: Expression of adiponectin or leptin is an independent prognosticatorAmerican Journal of Translational Research.  12:3033-3045. 2020
2020 Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder CancerFrontiers in Oncology.  10. 2020
2020 Reporting practices and resource utilization in the era of intraductal carcinoma of the prostate: A survey of genitourinary subspecialistsAmerican Journal of Surgical Pathology.  44:673-680. 2020
2020 FOXO1 as a tumor suppressor inactivated via AR/ERβ signals in urothelial cellsEndocrine-Related Cancer.  27:231-244. 2020
2020 Tumour immune microenvironment in primary and metastatic papillary renal cell carcinomaHistopathology.  76:423-432. 2020
2020 The Ever Changing Landscape of Anatomic Pathology PracticeAdvances in Anatomic Pathology.  27:1-2. 2020
2020 Updates on the Genomics of Bladder Cancer and Novel Molecular TaxonomyAdvances in Anatomic Pathology.  27:36-43. 2020
2019 PD-L1 expression in non–small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory-developed test using clone E1L3N in comparison with 22C3 and SP263 assaysHuman Pathology.  90:54-59. 2019
2019 Clinical implication of the mammalian target of rapamycin pathway in upper tract urothelial carcinoma with negative GATA binding protein 3 expressionInternational Journal of Urology.  26:678-679. 2019
2019 Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinomaCancer Science.  110:1771-1779. 2019
2019 INSL3 Expression in Leydig Cell Hyperplasia and Leydig Cell TumorsApplied Immunohistochemistry and Molecular Morphology.  27:203-209. 2019
2019 Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutationsHuman Pathology.  85:1-9. 2019
2019 p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid TumorsCancer Cell.  35:204-220.e9. 2019
2019 Expression of programmed cell death ligand 1 in non–small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 assayCancer Cytopathology.  127:52-61. 2019
2018 A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer ChiCTR16008041 ChiCTR 11 Medical and Health Sciences 1112 Oncology and CarcinogenesisCancer Communications.  38. 2018
2018 Erratum: Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy (eLife (2018) 7 PII: e43237)eLife.  7. 2018
2018 PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant CutoffsAmerican Journal of Surgical Pathology.  42:1384-1389. 2018
2018 Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor tsc mutations: Molecular analysis supports an expanding clinicopathologic spectrumAmerican Journal of Surgical Pathology.  42:1166-1181. 2018
2018 High-fat diet-induced inflammation accelerates prostate cancer growth via IL6 signalingClinical Cancer Research.  24:4309-4318. 2018
2018 Single 15-Min Protocol Yields the Same Cryoablation Size and Margin as the Conventional 10–8–10-Min Protocol: Results of Kidney and Liver Swine ExperimentCardioVascular and Interventional Radiology.  41:1089-1094. 2018
2018 Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate CancerAmerican Journal of Pathology.  188:1478-1485. 2018
2018 Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidyeLife.  7. 2018
2018 Re-evaluation of 33 ‘unclassified’ eosinophilic renal cell carcinomas in young patientsHistopathology.  72:588-600. 2018
2018 ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signalingEndocrine Connections.  7:1397-1408. 2018
2018 Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expressionBritish Journal of Cancer.  118:213-223. 2018
2018 YAP1 and COX2 coordinately regulate urothelial cancer stem-like cellsCancer Research.  78:168-181. 2018
2017 Prostate Cancer: An Update on Molecular Pathology with Clinical ImplicationsEuropean Urology Supplements.  16:253-271. 2017
2017 Pathology Imagebase—a reference image database for standardization of pathologyHistopathology.  71:677-685. 2017
2017 MicroRNAs, promising biomarkers in the diagnosis of Xp11 translocation RCC—replyHuman Pathology.  68:206-207. 2017
2017 Analytic, preanalytic, and clinical validation of p53 IHC for detection of TP53 missense mutation in prostate cancerClinical Cancer Research.  23:4693-4703. 2017
2017 Intravesical BCG Induces CD4+ T-cell expansion in an immune competent model of bladder cancerCancer Immunology Research.  5:594-603. 2017
2017 A phase II trial of dovitinib in BCG-unresponsive urothelial carcinoma with FGFR3 mutations or overexpression: Hoosier Cancer Research Network trial HCRN 12-157Clinical Cancer Research.  23:3003-3011. 2017
2017 GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticatorHuman Pathology.  64:83-90. 2017
2017 Urological cancer related to familial syndromesInternational Brazilian Journal of Urology.  43:192-201. 2017
2016 Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tractCancer Biology and Therapy.  17:1188-1196. 2016
2016 Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot StudyClinical Genitourinary Cancer.  14:e515-e520. 2016
2016 Clinical mutational profiling of bone metastases of lung and colon carcinoma and malignant melanoma using next-generation sequencingCancer Cytopathology.  124:744-753. 2016
2016 TFEB-amplified renal cell carcinomasAmerican Journal of Surgical Pathology.  40:1484-1495. 2016
2016 Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemCA: A Cancer Journal for Clinicians.  66:408-436. 2016
2016 Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologistsHistopathology.  69:441-449. 2016
2016 The intratumoral balance between metabolic and immunologic gene expression is associated with anti-PD-1 response in patients with renal cell carcinomaCancer Immunology Research.  4:726-733. 2016
2016 Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical CystectomyAnnals of Surgical Oncology.  23:2715-2722. 2016
2016 Extent of renal vein invasion influences prognosis in patients with renal cell carcinomaBJU International.  118:112-117. 2016
2016 Test feasibility of next-generation sequencing assays in clinical mutation detection of small biopsy and fine needle aspiration specimensAmerican Journal of Clinical Pathology.  145:696-702. 2016
2016 Germline variants in asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancerClinical Cancer Research.  22:448-458. 2016
2016 Frequent BRAF V600E mutations in metanephric stromal tumorAmerican Journal of Surgical Pathology.  40:719-722. 2016
2016 Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future PerspectiveBioMed Research International.  2016. 2016
2016 Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladderHuman Pathology.  47:20-25. 2016
2016 TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancersAmerican Journal of Surgical Pathology.  40:723-737. 2016
2016 Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk MenEuropean Urology.  69:157-165. 2016
2015 Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic AdenocarcinomasClinical Cancer Research.  21:5619-5629. 2015
2015 Renal carcinoma associated with a novel succinate dehydrogenase A mutation: A case report and review of literature of a rare subtype of renal carcinomaHuman Pathology.  46:1951-1955. 2015
2015 Androgen-regulated SPARCL1 in the tumor microenvironment inhibits metastatic progressionCancer Research.  75:4322-4334. 2015
2015 Smooth muscle and adenoma-like renal tumor: A previously unreported variant of mixed epithelial stromal tumor or a distinctive renal neoplasm?Human Pathology.  46:894-905. 2015
2015 GATA-3 expression in trophoblastic tissues: An immunohistochemical study of 445 cases, including diagnostic utilityAmerican Journal of Surgical Pathology.  39:101-108. 2015
2015 Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: A tissue microarray study of 149 patients treated by transurethral resectionHistopathology.  66:262-269. 2015
2015 Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical useCancer Prevention Research.  8:208-221. 2015
2015 Primary renal sclerosing epithelioid fibrosarcoma: Report of 2 cases with EWSR1-CREB3L1 gene fusionAmerican Journal of Surgical Pathology.  39:365-373. 2015
2015 Utility of uroplakin II expression as a marker of urothelial carcinomaHuman Pathology.  46:58-64. 2015
2014 Rb loss is characteristic of prostatic small cell neuroendocrine carcinomaClinical Cancer Research.  20:890-903. 2014
2014 Clear cell papillary renal cell carcinoma: Micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinomaHuman Pathology.  45:1130-1138. 2014
2014 Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: A tissue microarray study of 112 casesHistopathology.  64:863-871. 2014
2014 Long interspersed element-1 protein expression is a hallmark of many human cancersAmerican Journal of Pathology.  184:1280-1286. 2014
2014 Reduced glucocorticoid receptor expression predicts bladder tumor recurrence and progressionAmerican Journal of Clinical Pathology.  142:157-164. 2014
2014 Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendationsAnnales de Pathologie.  34:448-461. 2014
2014 T(6;11) Renal cell carcinoma (RCC): Expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed casesAmerican Journal of Surgical Pathology.  38:604-614. 2014
2014 VCL-ALK renal cell carcinoma in children with sickle-cell trait: The eighth sickle-cell nephropathy?American Journal of Surgical Pathology.  38:858-863. 2014
2013 TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urineCancer Research.  73:7162-7167. 2013
2013 Chromophobe renal cell carcinoma: Multiphase MDCT enhancement patterns and morphologic featuresAmerican Journal of Roentgenology.  201:1268-1276. 2013
2013 Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinomaHuman Pathology.  44:2668-2676. 2013
2013 Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethraHuman Pathology.  44:2760-2767. 2013
2013 The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomasHuman Pathology.  44:2651-2657. 2013
2013 Dysregulation of the mammalian target of rapamycin pathway in chromophobe renal cell carcinomasHuman Pathology.  44:2323-2330. 2013
2013 Renal cell carcinoma presenting with brain metastasis from a 1.6 cm primary tumorCanadian Journal of Urology.  20:6965-6967. 2013
2013 Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancerInternational Journal of Surgical Pathology.  21:352-357. 2013
2013 Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation serviceAmerican Journal of Surgical Pathology.  37:1150-1163. 2013
2013 Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumorsHuman Pathology.  44:1293-1299. 2013
2013 Determination of the nonlethal margin inside the visible "ice-ball" during percutaneous cryoablation of renal tissueCardioVascular and Interventional Radiology.  36:783-790. 2013
2013 Clinical applications of recent molecular advances in urologic malignancies: No longer chasing a "mirage"?Advances in Anatomic Pathology.  20:175-203. 2013
2013 Intrapancreatic accessory spleen: A case report and review of literatureDiagnostic Cytopathology.  41:466-469. 2013
2013 Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladderHuman Pathology.  44:612-622. 2013
2013 Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinomaCell Cycle.  12:1058-1070. 2013
2013 A broad survey of cathepsin k immunoreactivity in human neoplasmsAmerican Journal of Clinical Pathology.  139:151-159. 2013
2013 LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinomaExperimental and Molecular Pathology.  94:29-32. 2013
2013 Handling and staging of renal cell carcinoma: The International Society of Urological Pathology Consensus (ISUP) conference recommendationsAmerican Journal of Surgical Pathology.  37:1505-1517. 2013
2013 Renal tumors: Diagnostic and prognostic biomarkersAmerican Journal of Surgical Pathology.  37:1518-1531. 2013
2013 The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasiaAmerican Journal of Surgical Pathology.  37:1469-1489. 2013
2013 The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parametersAmerican Journal of Surgical Pathology.  37:1490-1504. 2013
2012 High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: A study using formalin-fixed, paraffin-embedded archival tissuesHuman Pathology.  43:1590-1595. 2012
2012 Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrumAmerican Journal of Surgical Pathology.  36:1516-1526. 2012
2012 Distribution and characterization of subtypes of penile intraepithelial neoplasia and their association with invasive carcinomas: A pathological study of 139 lesions in 121 patientsHuman Pathology.  43:1020-1027. 2012
2012 Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladderBJU International.  109:1716-1726. 2012
2012 Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: Further evidence for a biological distinctionAmerican Journal of Surgical Pathology.  36:783-784. 2012
2012 Results of live donor liver transplantation in patients with hepatitic C virus infection: The HCV 3 trial experienceClinical Transplantation.  26:502-509. 2012
2012 Emerging critical role of molecular testing in diagnostic genitourinary pathologyArchives of Pathology and Laboratory Medicine.  136:372-390. 2012
2012 Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escapeCancer Research.  72:917-927. 2012
2012 Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: A comparative histopathologic study from a single academic centerHuman Pathology.  43:254-260. 2012
2012 DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminomaBritish Journal of Cancer.  106:414-423. 2012
2011 Erratum: Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy (Cancer (2010) 116 (5517-26))Cancer.  117:5021. 2011
2011 Hepatocyte nuclear factor-1β expression in clear cell adenocarcinomas of the bladder and urethra: Diagnostic utility and implications for histogenesisHuman Pathology.  42:1613-1619. 2011
2011 PTEN protein loss by immunostaining: Analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patientsClinical Cancer Research.  17:6563-6573. 2011
2011 Immunoexpression status and prognostic value of mtor and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomasAmerican Journal of Surgical Pathology.  35:1549-1556. 2011
2011 Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypesAmerican Journal of Pathology.  179:1608-1615. 2011
2011 Diffuse expression of PAX2 and PAX8 in the cystic epithelium of mixed epithelial stromal tumor, angiomyolipoma with epithelial cysts, and primary renal synovial sarcoma: Evidence supporting renal tubular differentiationAmerican Journal of Surgical Pathology.  35:1264-1273. 2011
2011 Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? correlation with radical prostatectomy findingsAmerican Journal of Surgical Pathology.  35:1351-1355. 2011
2011 Adrenal lymphangioma: Clinicopathologic and immunohistochemical characteristics of a rare lesionHuman Pathology.  42:1013-1018. 2011
2011 High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, AfricaAmerican Journal of Hematology.  86:554-558. 2011
2011 Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomasAmerican Journal of Surgical Pathology.  35:1014-1020. 2011
2011 An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancerCancer Research.  71:3812-3821. 2011
2011 Genome-wide analysis of genetic alterations in testicular primary seminoma using high resolution single nucleotide polymorphism arraysGenomics.  97:341-349. 2011
2011 Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: An analysis using propensity score matchingBJU International.  107:1956-1962. 2011
2011 Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroidAmerican Journal of Surgical Pathology.  35:757-761. 2011
2011 Molecular diagnostics in urologic malignancies a work in progressArchives of Pathology and Laboratory Medicine.  135:610-621. 2011
2011 PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cellcarcinoma to the central nervous systemAmerican Journal of Surgical Pathology.  35:262-267. 2011
2011 Distinctive immunohistochemical profile of penile intraepithelial lesions: A study of 74 casesAmerican Journal of Surgical Pathology.  35:553-562. 2011
2010 Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatmentClinical Cancer Research.  16:5908-5913. 2010
2010 Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomyCancer.  116:5517-5526. 2010
2010 A distinctive subset of PEComas harbors TFE3 gene fusionsAmerican Journal of Surgical Pathology.  34:1395-1406. 2010
2010 Prostate melanosis associated with acinar adenocarcinomaInternational Journal of Surgical Pathology.  18:379-380. 2010
2010 Xp11 translocation renal cell carcinoma (RCC): Extended immunohistochemical profile emphasizing novel RCC markersAmerican Journal of Surgical Pathology.  34:1295-1303. 2010
2010 Low-grade papillary urothelial carcinoma of the urinary bladder: A clinicopathologic analysis of a post-world Health Organization/International Society of Urological Pathology classification cohort from a single academic centerArchives of Pathology and Laboratory Medicine.  134:1160-1163. 2010
2010 PAX8 (+)/p63 (-) Immunostaining pattern in renal collecting duct carcinoma (CDC): A useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tractAmerican Journal of Surgical Pathology.  34:965-969. 2010
2010 Renal medullary carcinoma: Molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapyBJU International.  106:62-65. 2010
2010 A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancerClinical Cancer Research.  16:3057-3066. 2010
2009 Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidneyAmerican Journal of Surgical Pathology.  33:1103-1106. 2009
2009 Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytologyHuman Pathology.  40:924-933. 2009
2009 Cyclophosphamide augments antitumor immunity: Studies in an autochthonous prostate cancer modelCancer Research.  69:4309-4318. 2009
2008 Papillary renal cell carcinoma with low-grade spindle cell foci: A mimic of mucinous tubular and spindle cell carcinomaAmerican Journal of Surgical Pathology.  32:1353-1359. 2008
2008 Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: Report of 21 casesAmerican Journal of Surgical Pathology.  32:461-467. 2008
2008 Fat-predominant mixed epithelial stromal tumor (MEST): Report of a unique case mimicking angiomyolipomaInternational Journal of Surgical Pathology.  16:73-77. 2008
2007 Colorectal adenocarcinoma involving the prostate: report of 9 casesHuman Pathology.  38:1836-1841. 2007
2007 Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancerCancer Research.  67:6136-6145. 2007
2007 Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: The role of morphology and immunohistochemistryArchives of Pathology and Laboratory Medicine.  131:599-603. 2007
2006 Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation - A clinical and histological examinationClinical Transplantation.  20:695-705. 2006
2006 Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation: Report of 5 cases and review of the literatureAmerican Journal of Surgical Pathology.  30:1372-1381. 2006
2006 Diagnostic molecular pathology: An increasingly indispensable tool for the practicing pathologistArchives of Pathology and Laboratory Medicine.  130:1339-1348. 2006
2006 Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: A significant likelihood of subsequently diagnosed adenocarcinomaAmerican Journal of Surgical Pathology.  30:1184-1188. 2006
2006 Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: The "Hepatitis C 3" multi-institutional trial experienceArchives of Pathology and Laboratory Medicine.  130:1157-1162. 2006
2006 Composite lymphocyte-rich Hodgkin lymphoma and peripheral T-cell lymphoma associated with Epstein-Barr virus: A case report and review of the literatureArchives of Pathology and Laboratory Medicine.  130:107-112. 2006
2005 Acute Graft versus host disease after liver transplantation: Patterns of lymphocyte chimerismAmerican Journal of Transplantation.  5:2968-2973. 2005
2005 Diagnostic molecular pathology, part 2: proteomics and clinical applications of molecular diagnostics in hematopathology.Baylor University Medical Center Proceedings.  18:7-12. 2005
2003 Diagnostic molecular pathology: current techniques and clinical applications, part I.Baylor University Medical Center Proceedings.  16:379-383. 2003
2003 A model to predict severe HCV-related disease following liver transplantationHepatology.  38:34-41. 2003
2003 Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patientsCancer Gene Therapy.  10:341-352. 2003
2003 Predictors for nonsentinel node involvement in breast cancer patients with micrometastases in the sentinel lymph node.Baylor University Medical Center Proceedings.  16:3-6. 2003
2003 Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis CAmerican Journal of Transplantation.  3:626-630. 2003
2001 Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: Safety, feasibility and biological activity 2001
2001 Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancerClinical Cancer Research.  7:691-703. 2001
2000 Fatal graft-versus-host disease associated with solid-organ transplantationBlood.  96. 2000
1999 Detection of low level benzene exposure in supermarket wrappers by urinary muconic acidBiomarkers.  4:106-117. 1999
1997 Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletionCancer Chemotherapy and Pharmacology.  40:376-384. 1997
1995 Changing Pattern of Expression of the Epidermal Growth Factor Receptor and Transforming Growth Factor α in the Progression of Prostatic NeoplasmsClinical Cancer Research.  1:545-550. 1995
1994 Molecular biologic aspects of human prostatic carcinoma.American Journal of Clinical Pathology.  102:S57-S64. 1994
1994 Molecular biologic aspects of human prostatic carcinomaAmerican Journal of Clinical Pathology.  102. 1994
1993 Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) mice 1993
1990 Sclerosing mediastieitis: Improved management with histoplasmosis titer and ketoconazoleAnnals of Thoracic Surgery.  50:215-221. 1990
1990 Steroid receptors in benign mastectomy tissueAmerican Journal of Clinical Pathology.  94:14-17. 1990

Book

Year Title Altmetric
2018 Genomic Applications in Pathology 2018
2014 Biopsy interpretation of the prostate: Fifth edition 2014

Chapter

Year Title Altmetric
2015 Prostate and seminal vesicles 2015
2013 Molecular pathology of urinary bladder cancer.  229-253. 2013
2011 Immunohistology of the Prostate, Bladder, Kidney, and Testis.  593-661. 2011
2010 The prostate and seminal vesicles.  1870-1913. 2010

Education And Training

  • Barnes Hospital, Washington University School of Medicine Lauren V. Ackerman Laboratory, Postdoctoral Research 1993
  • Doctor of Medicine, University of Damascus 1985
  • Baylor University Medical Center, Residency 1992
  • Baylor University Medical Center Pathology, Residency 1992
  • Baylor University Medical Center Pathology, Residency 1991
  • Memorial Sloan-Kettering Cancer Ctr, Postdoctoral Fellowship 1994
  • Memorial Sloan-Kettering Cancer Center, Postdoctoral Fellowship 1994
  • Barnes Hospital, Wash. U. S.O.M., Postdoctoral Fellowship 1993
  • Full Name

  • Georges Netto